Role of quantitative CSF microscopy to predict culture status and outcome in HIV-associated cryptococcal meningitis in a Brazilian cohort

Diagnostic Microbiology and Infectious Disease

Volumn 73, Issue 1, 2012, Pages 68-73

  Vidal, José E ^a,b   Gerhardt, Juliana ^a   Peixoto de Miranda, Érique J ^b   Dauar, Rafi F ^a   Oliveira Filho, Gilberto S ^a   Penalva de Oliveira, Augusto C ^a   Boulware, David R ^c  

^a INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Brazil; Cryptococcal meningitis; Cryptococcosis; Diagnosis; Outcome

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BLOOD CULTURE; BRAZIL; CD4+ T LYMPHOCYTE; CELL COUNT; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID CULTURE; CEREBROSPINAL FLUID EXAMINATION; CRYPTOCOCCAL MENINGITIS; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FUNGUS CULTURE; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSTRUMENT STERILIZATION; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MORTALITY; OUTCOME ASSESSMENT; PATHOGEN LOAD; PREDICTIVE VALUE; PRIORITY JOURNAL; QUANTITATIVE CEREBROSPINAL FLUID MICROSCOPY; VIRUS LOAD;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BRAZIL; CEREBROSPINAL FLUID; COHORT STUDIES; COLONY COUNT, MICROBIAL; DRUG MONITORING; FEMALE; HUMANS; MALE; MENINGITIS, CRYPTOCOCCAL; MICROSCOPY; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84860762380     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2012.01.014     Document Type: Article

References (26)

1. Bicanic T., Brouwer A.E., Meintjes G., Rebe K., Limmathurotsakul D., Chierakul W., et al. Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures. AIDS 2009, 23:701-706.
2. Bicanic T., Muzoora C., Brouwer A.E., Meintjes G., Longley N., Taseera K., et al. Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients. Clin. Infect. Dis. 2009, 49:702-709.
3. Bicanic T., Jarvis J., Loyse A., Jackson A., Muzoora C., Wilson D., et al. Determinants of acute outcome and long-term survival in HIV-associated cryptococcal meningitis: results from a combined cohort of 523 patients 2011.
4. Ganiem A.R., Parwati I., Wisaksana R., van der Zanden A., van de Beek D., Sturm P., et al. The effect of HIV infection on adult meningitis in Indonesia: a prospective cohort study. AIDS 2009, 23:2309-2316.
5. Guimarães M.D. Temporal study in AIDS-associated disease in Brazil, 1980-1999. Cad. Saude. Publica 2000.
6. Greco D.B., Simão M. Brazilian policy of universal access to AIDS treatment: sustainability challenges and perspectives. AIDS 2007, 21(Suppl 4):37-45.
7. Harrison T.S. The burden of HIV-associated cryptococcal disease. AIDS 2009, 23:531-532.
8. Jarvis J.N., Harrison T.S. HIV-associated cryptococcal meningitis. AIDS 2007, 21:2119-2129.
9. Jarvis J.N., Meintjes G., Williams A., Brown Y., Crede T., Harrison T.S. Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases. BMC Infect. Dis. 2010, 10:67.
10. Kambugu A., Meya D.B., Rhein J., O'Brien M., Janoff E.N., Ronald A.R., et al. Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy. Clin. Infect. Dis. 2008, 46:1694-1701.
11. Leimann B.C.Q., Koifman R.J. Official information systems for cryptococcal meningitis, state of Rio de Janeiro, Southeastern Brazil. Rev. Saúde Pública 2009, 43:1-4.
12. Lindenberg Ade S., Chang M.R., Paniago A.M., Lazéra Mdos S., Moncada P.M., Bonfim G.F., et al. Clinical and epidemiological features of 123 cases of cryptococcosis in Mato Grosso do Sul, Brazil. Rev. Inst. Med. Trop. Sao Paulo 2008, 50:75-78.
13. Longley N., Muzoora C., Taseera K., Mwesigye J., Rwebembera J., Chakera A., et al. Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda. Clin. Infect. Dis. 2008, 47:1556-1561.
14. Metta H.A., Corti M.E., Negroni R., Helou S., Arechavala A., Soto I., et al. Disseminated cryptococcosis in patients with AIDS. Clinical, microbiological, and immunological analysis of 51 patients. Rev. Argent. Microbiol. 2002, 34:117-123.
15. Mirza S.A., Phelan M., Rimland D., Graviss E., Hamill R., Brandt M.E., et al. The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas. Clin. Infect. Dis. 2003, 36:789-794.
16. Mónaco L.S., Tamayo Antabak N. Cryptococcosis in AIDS patients: case study from 1996 to 2006 in Paroissien Hospital. Rev. Argent. Microbiol. 2008, 40:218-221.
17. Mora D.J., da Cunha Colombo E.R., Ferreira-Paim K., Andrade-Silva L.E., Nascentes G.A., Silva-Vergara M.L. Clinical, epidemiological and outcome features of patients with cryptococcosis in Uberaba, Minas Gerais, Brazil. Mycopathologia 2011, [Epub ahead of print].
18. Moreira T.A., Ferreira M.S., Ribas R.M., Borges A.S. Cryptococcosis: clinical epidemiological laboratorial study and fungi varieties in 96 patients. Rev. Soc. Bras. Med. Trop. 2006, 39:255-258.
19. Pappalardo M.C.S.M., Melhem M.S.C. Cryptococcosis: a review of the Brazilian experience for the disease. Rev. Inst. Med. Trop. Sao Paulo 2003, 45:299-305.
20. Pappalardo M.C.S.M., Paschoal R.C., Melhem M.S.C. AIDS-Associated central nervous system cryptococcosis: a Brazilian case study. AIDS 2007, 21:1971-1983.
21. Park B.J., Wannemuehler K.A., Marston B.J., Govender N., Pappas P.G., Chiller T.M. Estimation of the global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009, 23:525-530.
22. Pasqualotto A.C., Severo C.B., Oliveira F.M., Severo L.C. Cryptococcemia. An analysis of 28 cases with emphasis on the clinical outcome and its etiologic agent. Rev. Iberoam. Micol. 2004, 21:143-146.
23. Prado M., Silva M.B., Laurenti R., Travassos L.R., Taborda C.P. Mortality due to systemic mycoses as a primary cause of death or in association with AIDS in Brazil: a review from 1996 to 2006. Mem. Inst. Oswaldo Cruz 2009, 104:513-521.
24. Satishchandra P., Nalini A., Gourie-Devi M., Khanna N., Santosh V., Ravi V., et al. Profile of neurologic disorders associated with HIV/AIDS from Bangalore, south India (1989-96). Indian J. Med. Res. 2000, 111:14-23.
25. Oliveira J.F., Greco D.B., Oliveira G.C., Christo P.P., Guimarães M.D., Oliveira R.C. Neurological disease in HIV-infected patients in the era of highly active antiretroviral treatment: a Brazilian experience. Rev. Soc. Bras. Med. Trop. 2006, 39:146-151.
26. Vidal J.E., Penalva de Oliveira A.C., Fink M.C., Pannuti C.S., Trujillo J.R. AIDS related progressive multifocal leukoencephalopathy: a retrospective study in a referral center in São Paulo, Brazil. Rev. Inst. Med. Trop. Sao Paulo 2008, 50:209-212.